Table 1 Demographic characteristics of EINSTEIN DVT and EINSTEIN PE patients combined
Rivaroxaban n = 4150 | Enoxaparin/VKA n = 4131 | |
|---|---|---|
Age, median (Q1–Q3), y | 58.0 (45.0–71.0) | 59.0 (45.0–70.0) |
Female sex, n (%) | 1848 (44.5) | 1917 (46.4) |
Weight, median (Q1–Q3), kg | 80.0 (70.0–93.0) | 80.0 (70.0–93.0) |
Creatinine clearance | ||
≥80 ml/min, n (%) | 2772 (66.8) | 2797 (67.7) |
Age, median (Q1–Q3), y | 50.0 (39.0–61.0) | 51.0 (40.0–61.0) |
Female sex, n (%) | 1113 (40.2) | 1140 (40.8) |
Weight, median (Q1–Q3), kg | 85.0 (74.0–98.0) | 85.0 (75.0–98.0) |
50–79 ml/min, n (%) | 1036 (25.0) | 1001 (24.2) |
Age, median (Q1–Q3), y | 71.0 (64.0–77.0) | 71.0 (65.0–77.0) |
Female sex, n (%) | 520 (50.2) | 553 (55.2) |
Weight, median (Q1–Q3), kg | 74.8 (65.0–82.0) | 74.0 (65.0–82.0) |
30–49 ml/min, n (%) | 323 (7.8) | 313 (7.6) |
Age, median (Q1–Q3), y | 80.0 (75.0–84.0) | 79.0 (75.0–83.0) |
Female sex, n (%) | 209 (64.7) | 210 (67.1) |
Weight, median (Q1–Q3), kg | 67.0 (59.0–75.1) | 67.8 (59.0–75.0) |
<30 ml/min, n (%) | 10 (0.2) | 11 (0.3) |
Age, median (Q1–Q3), y | 80.5 (73.0–86.0) | 79.0 (77.0–86.0) |
Female sex, n (%) | 5 (50.0) | 11 (100.0) |
Weight, median (Q1–Q3), kg | 60.0 (50.0–68.0) | 70.0 (48.0–75.0) |
Missing, n (%) | 9 (0.2) | 9 (0.2) |
Risk factors for VTE | ||
Unprovoked VTE, n (%) | 2003 (48.3) | 2048 (49.6) |
Previous VTE, n (%) | 791 (19.1) | 819 (19.8) |
Active cancer, n (%) | 232 (5.6) | 198 (4.8) |